KLM Laboratories Pvt. Ltd
bd_d9ebd61bd73119a8 · schema v1 · pii pii-v1
Full breach record for KLM Laboratories Pvt. Ltd →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group 8base on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
At KLM labs, our commitment, quality and precision makes us one of the most successful pharmaceutical companies. We provide quality healthcare products. KLM laboratories set up its foot in the pharmaceutical industry in 2010 with a vision of providing quality healthcare services to the community. We emerged as the top prescribers of Itraconazole in India in 2013, and we soon ventured into the international markets in 2015, making a thunderous proclamation. In 2017, We expanded our firm and launched a Pediatric Dermatology division. Another milestone was achieved in 2019 when KLM established itself in the domestic market in the Ophthalmology and Orthopedic sector. With over a decade of experience, we are India's top pharmaceutical company in dealing with dermatology, eye care, and ortho care. KLM laboratories global presence is enriched by over 1000 professionals, 55000 doctors affiliations, over 800 stockists expanded in ten-plus countries. Our firm is dedicated to serving two pharmaceutical divisions- Derma and Cosmo sectors that have built a niche in the international markets. We formulate high-quality tested and approved topical and oral solutions, immunomodulators, corticosteroid, anti-bacterial and anti-fungal solutions, including baby care products like shampoo formulations and moisturizing lotions. Our laboratory also ventures into ophthalmology by providing clinically tested eye drops and tablets. In addition, we also create oral formulations to treat ailments related to the musculoskeletal system. We are recognized as an enterprise that provides consumers access to the best pharmaceutical solutions while following a proactive approach to delivering better offerings that reflect modern medical. Commitment, quality, and precision make us one of the most successful pharmaceutical companies. Our strong beliefs and hardcore values have helped us establish a 'corpo
Source provenance
- Source URL
- https://www.ransomware.live/id/S0xNIExhYm9yYXRvcmllcyBQdnQuIEx0ZEA4YmFzZQ==
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Aug 26, 2023
- Raw hash
- af018c3c209a2d37eedb17cdb759383ad1159c71981db649d1cfddf9a7a59b95
Reporting entity
- Name
- 8base
Victim entity
- Name
- KLM Laboratories Pvt. Ltdnorm: klm laboratories pvt
- Domain
- klmlab.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· 8base
- Threat actor
- 8baseExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.